$HBPCF News
Last published 1y ago
- 1y agoHBPCHBPCFEarnings Call - HELIX BIOPHARMA CORPEarnings Call TranscriptsGood day and welcome to Q3 Investor Summit Virtual. We appreciate your participation in today's virtual event. Up next, we are pleased to introduce Helix Biopharma Corporation. If you would like to ask a question during
- 4y agoHBPCFJerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.ACCESS NewswireVANCOUVER, BC / ACCESSWIRE / April 22, 2022 / Mr. Jerzy Wilczewski announces the acquisition of 7,700,000 common shares ("Common Shares") in the capital of Helix Biopharma Corp. ("Helix" or the "Company") (TSX: HBP) at a price of $0.26 per Common Share b
- 4y agoHBPCFHelix Biopharma Corp. Closes Private PlacementACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / April 21, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological p
- 4y agoHBPCFHelix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board MembersACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / April 18, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological p
- 4y agoHBPCFHelix Biopharma Corp. Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement SubscriptionACCESS NewswireRICHMOND, ON / ACCESSWIRE / April 13, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platfo
- 4y agoHBPCFHelix Announces Board ResignationACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / April 7, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological pl
- 4y agoHBPCFHelix Biopharma Corp. Announces Management and Board ChangesACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / March 22, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological p
- 4y agoHBPCFHelix Biopharma Corp. Announces Fiscal 2022 Second Quarter ResultsACCESS NewswireRICHMOND, ON / ACCESSWIRE / March 16, 2022 / Helix BioPharma Corp. (TSX:HBP), (" Helix " or the " Company "), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological pl
- 4y agoHBPCFHelix Biopharma Corp. Announces Unexpected Passing of Interim CEO and Chairman of the BoardACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / March 16, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company") today announces, with great sadness, the sudden passing of its Interim Chief Executive Officer and Chairman of the Board of Directors (the "Board
- 4y agoHBPCFCORRECTION: Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise PeriodACCESS Newswire(This release corrects the release that was posted earlier on March 11, 2022 due to the incorrect company logo being added. This release adds the corrected logo) RICHMOND HILL, ON / ACCESSWIRE / March 11, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix"
- 4y agoHBPCFHelix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise PeriodACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / March 11, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological p
- 4y agoHBPCFHelix BioPharma Corp. Reports Voting Results and Appointment of New Board DirectorACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / January 28, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced the voting result
- 4y agoHBPCFHelix BioPharma Corp. Provides Corporate UpdateACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / December 31, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to provide a corporat
- 4y agoHBPCFHelix Biopharma Corp. Announces Fiscal 2022 First Quarter ResultsACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / December 15, 2021 / Helix BioPharma Corp. (TSX:HBP), (" Helix " or the " Company "), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technolo
- 4y agoHBPCFHelix BioPharma Corp. Extends Period to Exercise WarrantsACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / December 14, 2021 / Helix BioPharma Corp. (TSX:HBP)(FSE:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it
- 4y agoHBPCFHelix Biopharma Corp. Announces Fiscal 2021 Year-End ResultsACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / December 9, 2021 / Helix BioPharma Corp. (TSX:HBP), (" Helix " or the " Company "), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technolog
- 4y agoHBPCFHelix BioPharma Corp. Provides Third Bi-Weekly MCTO Status UpdateACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / November 30, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is providing this bi-weekly upda
- 4y agoHBPCFHelix BioPharma Corp. Provides Second Bi-Weekly MCTO Status UpdateACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / November 15, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is providing this bi-weekly upda
- 5y agoHBPCFHelix BioPharma Corp. Provides Bi-Weekly MCTO Status UpdateACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / November 1, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is providing this bi-weekly updat
- 5y agoHBPCFHelix BioPharma Corp. Announces Delay of Annual FilingsACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / October 15, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced today that it anticipat
- 5y agoHBPCFHelix BioPharma Corp. Announces Appointment of Interim Chief Executive OfficerACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / September 20, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that the Compan
- 5y agoHBPCFHelix BioPharma Corp. Announces Appointment of New DirectorACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / August 19, 2021 / Helix BioPharma Corp. (TSX:HBP) ('Helix' or the 'Company'), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that Dr. Krzysztof
- 5y agoABMLAVCODMPWWEPWCF+9Proactive news headlines including AEX Gold, Helix BioPharma, Imagine AR, Empower Clinics and Kintara TherapeuticsGlobeNewswireNew York , July 01, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Exactus Inc (OTCQB:EXDI) buys Colorado hemp produc
- 5y agoHBPCFHelix BioPharma Corp. Announces Changes to the Company's Board of Directors and ManagementACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / June 30, 2021 / Helix BioPharma Corp. (TSX:HBP) ('Helix' or the 'Company'), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that Heman Chao has
- 5y agoHBPCFHelix BioPharma Corp. Announces Appointment of New Auditor and Extends Period to Exercise WarrantsACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / June 24, 2021 / Helix BioPharma Corp. (TSX:HBP) ('Helix' or the 'Company'), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has appointe
- 5y agoARECAUIAFBIOCBSGM+12Proactive news headlines including Nextleaf Solutions, KushCo Holdings, INDVR Brands and Aurania ResourcesGlobeNewswireNew York , June 15, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies: BioHarvest Sciences Inc (CSE:BHSC) (OTC:CNVCF) (FRA:8MV) d
- 5y agoHBPCFHelix BioPharma Corp. Announces Fiscal Third Quarter 2021 ResultsACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / June 14, 2021 / Helix BioPharma Corp. (TSX:HBP), a an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the fiscal third quarter ended
- 5y agoHBPCFHelix BioPharma Corp. Announces Closing of First Tranche of Institutional Investment for Gross Proceeds of CAD$3.5 millionACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / May 13, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has closed th
- 5y agoHBPCFHelix BioPharma Corp. Announces Institutional Investment for Gross Proceeds of up to CAD$10 millionACCESS NewswireRICHMOND HILL, ON / ACCESSWIRE / May 11, 2021 / Helix BioPharma Corp.(TSX:HBP)("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it has entered int